Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells

<div>(a) Association between the expression levels of <i>CCND1, SIRT2, AURKB, VEGFA, HDAC1, CASP9,</i><i>HSP90AA1</i>, and <i>HSP90AB1</i> and the overall survival in the breast cancer samples from The Cancer Genome Atlas. (b) Correlation analysis between the expression levels of <i>CCND1, SIRT2, AURKB, VEGFA, HDAC1, CASP9, HSP90AA1</i>, and <i>HSP90AB1</i> and the infiltration levels of B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells 

Figure 3 | Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells 